Elysium Health
PrivateLast Round
Series C
Dec 23, 2019
Est. Valuation
$157M
Total Funding Raised
$80M
Company Overview
Elysium Health is a life sciences company that develops and sells clinically validated health products and supplements based on scientific research in aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, E-commerce, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elysium Health Comparables
Compare Elysium Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qualia Life Sciences | 86% | |
| Niagen Bioscience, Inc. | 85% | |
| NOVOS | 83% |
Elysium Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 23, 2019 | ||||
| Debt | Jun 29, 2017 | ||||
| Series B | Dec 6, 2016 | ||||
| Seed | Feb 1, 2014 |
Elysium Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series C |
| Breyer Capital | Series C, Series B |
| Greylock Partners | Series A |
| Morningside Ventures | Series A, Series C, Series B |
| General Catalyst | Series C, Series B |
| Mayo Clinic Ventures | Series C |
| Sound Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2025
Launched COFACTOR, a 4-in-1 collagen and NAD+ system.
- Dec 23, 2019
Raised $40M led by GISEV.
Recent news
Latest coverage and updates
- opens_new_locationSep 10, 2026
Elysium Health opened new location in New York, New York, United States, Northern America, Americas on Sep 9th '26.
- launchesJun 17, 2026
Elysium Health launched creatine+ on Jun 15th '26.
Elysium Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elysium Health's valuation, stock price, and market status.
Is Elysium a public or private company?
Elysium is a private company.
What is the current stock price of Elysium?
Elysium is a private company with no public stock price. No recent secondary market data is available.
How much is Elysium worth (valuation)?
Elysium's valuation is estimated at $157.0M based on funding round data.
Can I buy Elysium stock?
Elysium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elysium's last funding round?
Elysium's most recent funding round was Series C on December 6, 2016.
Who are the main investors in Elysium?
Key investors in Elysium include GISEV, General Catalyst.
Will Elysium IPO soon?
No public IPO plans have been announced for Elysium.
How can I track Elysium secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elysium's secondary market activity and sign up for updates.